Kane K P
Department of Immunology, University of Alberta, Edmonton, Canada.
J Exp Med. 1994 Mar 1;179(3):1011-5. doi: 10.1084/jem.179.3.1011.
Ly-49 is a recently identified cell surface molecule expressed on a subpopulation of natural killer (NK) cells and certain T lymphomas. It has been suggested, based on gene transfection and antibody blocking studies, that Ly-49 is a negative regulator of NK lytic activity, possibly through an interaction with target cell class I molecules. However, it has not been demonstrated that class I molecules indeed serve as ligands for Ly-49. We have found that T lymphomas expressing Ly-49 bind isolated class I major histocompatibility complex (MHC) molecules but not class II molecules immobilized on plastic. Adhesion to class I molecules was not found with T lymphomas lacking Ly-49 expression. The Ly-49 expressing EL4 lymphoma bound Dd, Dk, and Kb, but not Kd, Kk, or Db, thus demonstrating a restricted pattern of class I adhesion. The observed cell adhesion was class I density dependent, and binding to Dd and Dk was extensively inhibited by the A1 monoclonal antibody directed against Ly-49. These results provide direct evidence for Ly-49 serving as a receptor for a subset of class I MHC molecules.
Ly-49是最近发现的一种细胞表面分子,在自然杀伤(NK)细胞亚群和某些T淋巴瘤上表达。基于基因转染和抗体阻断研究表明,Ly-49可能是NK细胞杀伤活性的负调节因子,可能是通过与靶细胞I类分子相互作用实现的。然而,尚未证实I类分子确实是Ly-49的配体。我们发现,表达Ly-49的T淋巴瘤能结合分离的I类主要组织相容性复合体(MHC)分子,但不结合固定在塑料上的II类分子。缺乏Ly-49表达的T淋巴瘤未发现与I类分子的黏附。表达Ly-49的EL4淋巴瘤能结合Dd、Dk和Kb,但不结合Kd、Kk或Db,从而证明了I类黏附的受限模式。观察到的细胞黏附依赖于I类分子的密度,并且针对Ly-49的A1单克隆抗体可广泛抑制与Dd和Dk的结合。这些结果为Ly-49作为I类MHC分子子集的受体提供了直接证据。